THOR MEDICAL ASA
Thor Medical | Alpha emitters for cancer therapy
Thor Medical will become the world leading supplier of alpha emitters for cancer therapy.
Links
Organization
- CEO
- JC
- Chairman of the board
- JA
John Andersen1967
- Years since formation
- 16 years
- since Jul 7, 2009
- Type
- Public limited company
- VAT registered
- Yes
- Number of employees
- 14
Ownership
- Number of shares and share classes
- 280,492,395
- 1 share class
- Total number of shareholders
- 13920
- 641 companies, 13,279 persons
- Belongs to group of
Financials
- Annual total result 2024
- -40,593,000
- NOK
- Total equity 2024
- 341,463,000
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
JC | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
MK | Board Member | - |
JA 1967 | Chairman | - |
AU | Board Member | - |
TR 1956 | Board Member | - |
JG | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
TB | - | 16.37 % indirectly |
CB | - | 2.32 % indirectly |
MB | - | 2.32 % indirectly |
| - | 2.32 % indirectly | |
JD | - | 2.21 % indirectly |
BG | - | 2.21 % indirectly |
CD | - | 1.54 % indirectly |
JM 1973 | - | 1.53 % directly |
RF | - | 1.38 % directly 0.34 % indirectly 1.04 % |
CR | - | 1.16 % indirectly |
Last update: May 14, 2025
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| NO0010597883 | 64,417,932 | 22.97 % | |
| NO0010597883 | 11,794,640 | 4.2 % | |
| NO0010597883 | 10,532,567 | 3.76 % | |
| NO0010597883 | 8,000,000 | 2.85 % | |
| NO0010597883 | 6,200,000 | 2.21 % | |
| NO0010597883 | 4,710,130 | 1.68 % | |
JM 1973 | NO0010597883 | 4,300,000 | 1.53 % |
| NO0010597883 | 4,255,892 | 1.52 % | |
| NO0010597883 | 3,714,806 | 1.32 % | |
| NO0010597883 | 3,165,920 | 1.13 % | |
| NO0010597883 | 2,910,000 | 1.04 % | |
| NO0010597883 | 2,153,479 | 0.77 % | |
| NO0010597883 | 2,000,000 | 0.71 % | |
| NO0010597883 | 1,815,781 | 0.65 % | |
| NO0010597883 | 1,584,324 | 0.56 % | |
| NO0010597883 | 1,538,543 | 0.55 % | |
EK | NO0010597883 | 1,513,500 | 0.54 % |
| NO0010597883 | 1,416,021 | 0.5 % | |
| NO0010597883 | 1,405,758 | 0.5 % | |
| NO0010597883 | 1,177,396 | 0.42 % | |
AF | NO0010597883 | 1,080,566 | 0.39 % |
JP | NO0010597883 | 1,002,099 | 0.36 % |
| NO0010597883 | 1,000,000 | 0.36 % | |
| NO0010597883 | 989,163 | 0.35 % | |
RF | NO0010597883 | 965,617 | 0.34 % |
| NO0010597883 | 915,440 | 0.33 % | |
GF 1955 | NO0010597883 | 881,000 | 0.31 % |
| NO0010597883 | 846,000 | 0.3 % | |
TE 1953 | NO0010597883 | 800,000 | 0.29 % |
| NO0010597883 | 792,941 | 0.28 % | |
SA 1965 | NO0010597883 | 783,700 | 0.28 % |
| NO0010597883 | 743,565 | 0.27 % | |
AS 1970 | NO0010597883 | 729,000 | 0.26 % |
HR | NO0010597883 | 708,916 | 0.25 % |
| NO0010597883 | 700,546 | 0.25 % | |
BL 1949 | NO0010597883 | 700,220 | 0.25 % |
| NO0010597883 | 700,000 | 0.25 % | |
| NO0010597883 | 652,000 | 0.23 % | |
| NO0010597883 | 642,801 | 0.23 % | |
| NO0010597883 | 627,114 | 0.22 % | |
CS | NO0010597883 | 571,905 | 0.2 % |
| NO0010597883 | 563,712 | 0.2 % | |
KA | NO0010597883 | 563,538 | 0.2 % |
TR 1990 | NO0010597883 | 558,559 | 0.2 % |
| NO0010597883 | 550,000 | 0.2 % | |
KØ | NO0010597883 | 549,000 | 0.2 % |
FB | NO0010597883 | 545,000 | 0.19 % |
| NO0010597883 | 541,247 | 0.19 % | |
SN 1969 | NO0010597883 | 515,175 | 0.18 % |
JS 1940 | NO0010597883 | 500,000 | 0.18 % |
| NO0010597883 | 495,370 | 0.18 % | |
| NO0010597883 | 490,970 | 0.18 % | |
LS 1949 | NO0010597883 | 486,489 | 0.17 % |
| NO0010597883 | 450,000 | 0.16 % | |
| NO0010597883 | 446,759 | 0.16 % | |
| NO0010597883 | 434,385 | 0.15 % | |
AS 1966 | NO0010597883 | 424,000 | 0.15 % |
| NO0010597883 | 419,454 | 0.15 % | |
MK | NO0010597883 | 416,990 | 0.15 % |
MS 1959 | NO0010597883 | 412,000 | 0.15 % |
| NO0010597883 | 400,000 | 0.14 % | |
ES 1988 | NO0010597883 | 395,662 | 0.14 % |
| NO0010597883 | 390,000 | 0.14 % | |
OH 1962 | NO0010597883 | 390,000 | 0.14 % |
MA 1955 | NO0010597883 | 380,000 | 0.14 % |
SJ | NO0010597883 | 367,734 | 0.13 % |
| NO0010597883 | 353,185 | 0.13 % | |
| NO0010597883 | 350,364 | 0.12 % | |
| NO0010597883 | 350,000 | 0.12 % | |
| NO0010597883 | 344,996 | 0.12 % | |
| NO0010597883 | 340,083 | 0.12 % | |
| NO0010597883 | 336,550 | 0.12 % | |
| NO0010597883 | 324,841 | 0.12 % | |
TD 1977 | NO0010597883 | 304,000 | 0.11 % |
| NO0010597883 | 303,571 | 0.11 % | |
| NO0010597883 | 300,000 | 0.11 % | |
TA 1959 | NO0010597883 | 295,000 | 0.11 % |
SO | NO0010597883 | 294,000 | 0.1 % |
BM | NO0010597883 | 285,000 | 0.1 % |
OH | NO0010597883 | 282,000 | 0.1 % |
LM 1966 | NO0010597883 | 281,932 | 0.1 % |
TV 1969 | NO0010597883 | 280,000 | 0.1 % |
| NO0010597883 | 277,303 | 0.1 % | |
TT | NO0010597883 | 274,194 | 0.1 % |
TH | NO0010597883 | 264,600 | 0.09 % |
TS 1968 | NO0010597883 | 260,010 | 0.09 % |
EH 1986 | NO0010597883 | 254,628 | 0.09 % |
| NO0010597883 | 251,000 | 0.09 % | |
JE | NO0010597883 | 250,000 | 0.09 % |
AA | NO0010597883 | 245,634 | 0.09 % |
| NO0010597883 | 241,279 | 0.09 % | |
ES 1981 | NO0010597883 | 240,000 | 0.09 % |
TB | NO0010597883 | 234,781 | 0.08 % |
BS 1968 | NO0010597883 | 232,500 | 0.08 % |
| NO0010597883 | 230,370 | 0.08 % | |
TM 1971 | NO0010597883 | 225,000 | 0.08 % |
| NO0010597883 | 220,880 | 0.08 % | |
FR 1953 | NO0010597883 | 213,997 | 0.08 % |
SR 1969 | NO0010597883 | 213,799 | 0.08 % |
RB 1962 | NO0010597883 | 211,596 | 0.08 % |
Shares owned by the THOR MEDICAL ASA
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 641,732 | 100 % |
Last update: Jun 2, 2025
Group structure
- Total operating income 2024: NOK 0Operating profit 2024: NOK -41,946,000Employees: 14
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -40,593,000 | -2,855,000 | -310,251,000 | -433,151,000 |
Total assets | 363,926,000 | 278,406,000 | 95,301,000 | 281,528,000 |
Total liabilities | 22,462,000 | 3,777,000 | 42,079,000 | 151,189,000 |
Total equity | 341,463,000 | 274,629,000 | 53,222,000 | 130,339,000 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 41,946,000 | 4,356,000 | 325,323,000 | 445,164,000 |
Operating result | -41,946,000 | -4,356,000 | -325,323,000 | -445,164,000 |
Financial income/costs | 1,353,000 | 1,501,000 | 15,179,000 | 12,149,000 |
Profit before tax | -40,593,000 | -2,855,000 | -310,144,000 | -433,015,000 |
Total tax & extraordinary income/cost | 0 | 0 | 107,000 | 136,000 |
Annual Total Result | -40,593,000 | -2,855,000 | -310,251,000 | -433,151,000 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 234,847,000 | 234,728,000 | 674,000 | 6,080,000 |
Total current assets | 129,079,000 | 43,678,000 | 94,627,000 | 275,448,000 |
Total assets | 363,926,000 | 278,406,000 | 95,301,000 | 281,528,000 |
Short term debt | 22,462,000 | 3,777,000 | 42,079,000 | 151,189,000 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 22,462,000 | 3,777,000 | 42,079,000 | 151,189,000 |
Contributed capital | 400,204,000 | 292,777,000 | 55,624,000 | 162,491,000 |
Retained earnings | -58,741,000 | -18,148,000 | -2,402,000 | -32,152,000 |
Total equity | 341,463,000 | 274,629,000 | 53,222,000 | 130,339,000 |
Total equity and liabilities | 363,925,000 | 278,406,000 | 95,301,000 | 281,528,000 |
Classification
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises